Pharmacotherapy for obsessive—compulsive disorder-Reference-Cited by-同舟云学术

Pharmacotherapy for obsessive—compulsive disorder

Published:2011-11 Issue:6 Volume:17 Page:419-434
ISSN:1355-5146
Container-title:Advances in Psychiatric Treatment
language:en
Short-container-title:Adv. psychiatr. treat

Author:

Fineberg Naomi,Brown Angus

Abstract

SummaryWe present a narrative review of evidence-based treatment for obsessive–compulsive disorder (OCD), covering first-line pharmacological treatment, augmentation strategies, approaches for treatment-refractory OCD and the management of OCD in special populations (children and adolescents, pregnant and breast-feeding women, and elderly people).

Publisher

Cambridge University Press (CUP)

Subject

Psychiatry and Mental health

Reference119 articles.

1. High doses of sertraline for treatment-resistant obsessive–compulsive disorder;Byerly;American Journal of Psychiatry,1996

2. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis

3. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

4. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

5. The procedures mentioned in this section are discussed in Advances by Christmas et al (2004) Neurosurgery for mental disorder, 10: 189–199. Ed.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradigm shift required for translational research on the brain;Experimental & Molecular Medicine;2024-05-01

2. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications;Comprehensive Psychiatry;2022-10

3. Obsessive-compulsive disorder and related disorders;InnovAiT: Education and inspiration for general practice;2022-07-28

4. Repetitive Transcranial Magnetic Stimulation (r-TMS) and Selective Serotonin Reuptake Inhibitor-Resistance in Obsessive-Compulsive Disorder a Meta-Analysis and Clinical Implications;SSRN Electronic Journal;2022

5. Obsessive–compulsive disorder—contamination fears, features, and treatment: novel smartphone therapies in light of global mental health and pandemics (COVID-19);CNS Spectrums;2020-10-21